Detect thinking decline using recordings
- Trial ID
- NCT06640673
- Official Title
- Electrophysiological Signature of Mild Cognitive Impairment and Its Relationship with Parkinson's Disease: a High-density EEG Investigation
- Goal
- Detect thinking decline using recordings
- Status
- RECRUITING
- Sponsor
- IRCCS San Camillo, Venezia, Italy
- Study Type
- OBSERVATIONAL
- Enrollment
- 42 participants
- Conditions
- Parkinson Disease, Parkinson Disease, Mild Cognitive Impairment, Healthy
- Interventions
- Hd-EEG
Plain-Language Summary
The team wants to identify an electrical brain signature that marks mild cognitive impairment in people with Parkinson's and to compare those signals with healthy aging. They will record high-density EEG, which maps brain electrical rhythms across many scalp sites to detect subtle slowing or connectivity changes, and because the work is observational it does not change treatment so participants may be taking stable doses of levodopa, antidepressants, or cholinesterase drugs. They are enrolling adults 50 to 90 who can walk independently, who do not have severe dementia and have relatively preserved cognition on screening (MMSE >24 or MoCA >15.5), with any Parkinson's or related medications kept stable for at least four weeks.
Locations
- IRCCS San Camillo S.R.L, Lido, Italy, Italy
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Hd-EEG. The team wants to identify an electrical brain signature that marks mild cognitive impairment in people with Parkinson's and to compare those signals with healthy aging. They will record high-density EEG, which maps brain electrical rhythms across many scalp sites to detect subtle slowing or connectivity changes, and because the work is observational it does not change treatment so participants may be taking stable doses of levodopa, antidepressants, or cholinesterase drugs. They are enrolling adults 50 to 90 who can walk independently, who do not have severe dementia and have relatively preserved cognition on screening (MMSE >24 or MoCA >15.5), with any Parkinson's or related medications kept stable for at least four weeks.
- Who can participate?
- Participants must be between 50 Years and 90 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 5 months.